| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | -8.9B | -281% |
| Gross Profit | -5.7B | -279% |
| Cost Of Revenue | 2.1B | +21% |
| Operating Income | 1.3B | +35% |
| Operating Expenses | 2.4B | +10% |
| Net Income | -879MM | -227% |
| R&D | 350MM | -1% |
| G&A | 1.9B | +14% |
| Amortization | 149MM | -9% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
Robotics and related technologies, such as workflow automation products, cloud services, and generative AI technology, have captivated the investing community. They have assisted in leading the overall market higher over this past year especially. Investors are very interested in technology companies focused on innovation and the rollout of brand-new products and services. With the technology sector booming, it’s a perfect time for investors to jump into these robotics companies with a great fut
Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.